(Q48253639)

English

Discriminant power of combined cerebrospinal fluid tau protein and of the soluble interleukin-6 receptor complex in the diagnosis of Alzheimer's disease.

scientific article published in March 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/10095017

Discriminant power of combined cerebrospinal fluid tau protein and of the soluble interleukin-6 receptor complex in the diagnosis of Alzheimer's disease. (English)

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/10095017

Alzheimer's disease

0 references

cerebrospinal fluid

0 references

Stefan J Teipel

2

object named as

Teipel SJ

1 reference

Europe PubMed Central

10 February 2018

Stanley I. Rapoport

15

object named as

Rapoport SI

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/10095017

Hans-Jürgen Möller

16

object named as

Möller HJ

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/10095017

author name string

Hampel H

1

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/10095017

Padberg F

3

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/10095017

Haslinger A

4

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/10095017

Riemenschneider M

5

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/10095017

Schwarz MJ

6

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/10095017

Kötter HU

7

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/10095017

Scheloske M

8

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/10095017

Buch K

9

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/10095017

Stübner S

10

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/10095017

Dukoff R

11

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/10095017

Lasser R

12

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/10095017

Müller N

13

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/10095017

Sunderland T

14

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/10095017

language of work or name

0 references

publication date

1 March 1999

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/10095017

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/10095017

823

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/10095017

104-112

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/10095017

1-2

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/10095017

Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

Tau in cerebrospinal fluid: a potential diagnostic marker in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

Early detection of Alzheimer's disease: a statistical approach using positron emission tomographic data

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

Interleukin-6 and α-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

Evidence of subtypes of Alzheimer's disease and implications for etiology

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

Discriminant analysis of MRI measures as a method to determine the presence of dementia of the Alzheimer type.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

“Mini-mental state”

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

Interleukin-6 is not altered in cerebrospinal fluid of first-degree relatives and patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

Decreased soluble interleukin-6 receptor in cerebrospinal fluid of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

Measurement of distinct immunochemical presentations of tau protein in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

Molecular cloning and expression of an IL-6 signal transducer, gp130

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

IL-6 cytokine family and signal transduction: a model of the cytokine system

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

Coadministration of interleukin-6 (IL-6) and soluble IL-6 receptor delays progression of wobbler mouse motor neuron disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

CNTF and LIF act on neuronal cells via shared signaling pathways that involve the IL-6 signal transducing receptor component gp130

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

Increased cerebrospinal fluid tau in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

Longitudinal study of cerebrospinal fluid levels of tau, A beta1-40, and A beta1-42(43) in Alzheimer's disease: a study in Japan.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

Epitopes that span the tau molecule are shared with paired helical filaments.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

Examination of phosphorylated tau protein as a PHF-precursor at early stage Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

Sympathetic neurons can produce and respond to interleukin 6

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

Expression of interleukin-6 receptor (IL-6R) and gp130 mRNA in PC12 cells and sympathetic neurons: modulation by tumor necrosis factor alpha (TNF-alpha).

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

Activation of gp 130 by IL-6/soluble IL-6 receptor induces neuronal differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

Interleukin-6 (IL-6) and soluble forms of IL-6 receptors are not altered in cerebrospinal fluid of Alzheimer's disease patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

Microtubular reorganization and dendritic growth response in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

Staging the pathological assembly of truncated tau protein into paired helical filaments in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

A progressive deposition of paired helical filaments (PHF) in the brain characterizes the evolution of dementia in Alzheimer's disease. An immunocytochemical study with a monoclonal antibody against the PHF core.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

Tau in cerebrospinal fluids: establishment of the sandwich ELISA with antibody specific to the repeat sequence in tau.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

Differential shedding of the two subunits of the interleukin-6 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

Protein kinase C activity is rate limiting for shedding of the interleukin-6 receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

The soluble interleukin-6 receptor is generated by shedding

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

Receptors for B-cell stimulatory factor-1 expressed on cells of haematopoietic lineage

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

Two distinct and independent sites on IL-6 trigger gp 130 dimer formation and signalling

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

Cardiotrophin-1: a multifunctional cytokine that signals via LIF receptor-gp 130 dependent pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

Cerebrospinal protein tau is elevated in early Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

Diagnosis of Alzheimer's disease with cerebrospinal fluid tau protein and aspartate aminotransferase

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

Enhancement of beta-amyloid precursor protein transcription and expression by the soluble interleukin-6 receptor/interleukin-6 complex.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

Inflammation and Alzheimer's disease pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

Total tau protein immunoreactivity in lumbar cerebrospinal fluid of patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

Induction of neuronal differentiation in PC12 cells by B-cell stimulatory factor 2/interleukin 6

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

Combination assay of CSF tau, A beta 1-40 and A beta 1-42(43) as a biochemical marker of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

A population-based study of tau protein and ubiquitin in cerebrospinal fluid in 85-year-olds: relation to severity of dementia and cerebral atrophy, but not to the apolipoprotein E4 allele.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

1.9 A crystal structure of interleukin 6: implications for a novel mode of receptor dimerization and signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

Gp130, a shared signal transducing receptor component for hematopoietic and neuropoietic cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

Tau protein concentrations in cerebrospinal fluid of patients with dementia of the Alzheimer type

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease” 11The names of the Working Group Members and the names of the Working Group Advisory Committee Members are listed in the Appendix A(section VI)

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

Elevation of microtubule-associated protein tau in the cerebrospinal fluid of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

Characteristic localization of gp130 (the signal-transducing receptor component used in common for IL-6/IL-11/CNTF/LIF/OSM) in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1 beta or IL-1RA but increases in the associated acute phase proteins IL-6, alpha 2-macroglobulin and C-reactive protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

Purification and characterization of soluble human IL-6 receptor expressed in CHO cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

Evidence for the formation of a heterotrimeric complex of leukaemia inhibitory factor with its receptor subunits in solution

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901146-4

7 January 2021

Identifiers

10.1016/S0006-8993(99)01146-4

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/10095017

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/10095017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48253639&oldid=1798125276"